Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5721244 | ABBVIE | Combination of angiotensin-converting enzyme inhibitors with calcium antagonists as well as their use in drugs |
Feb, 2015
(9 years ago) |
Market Authorisation Date: 22 October, 1996
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL